Thai Q1 GDP growth beats forecast, but full-year forecast cut due to tariffs
BANGKOK: Thailand's economy grew more than expected in the first quarter of 2025, data showed on Monday, but the state planning agency slashed its full-year growth and trade forecasts as US tariffs threaten the country's export engine.
Thailand faces a 36 per cent tariff on shipments to the US, its biggest export market, if a reduction cannot be negotiated before a moratorium expires in July.
The economy grew 3.10 per cent in the January-March quarter from a year earlier, the National Economic and Social Development Council (NESDC) said, above market expectations of 2.90 per cent growth and just below the 3.30 per cent pace in the previous quarter, the NESDC said.
The agency cut its 2025 economic growth forecast to between 1.30 per cent and 2.30 per cent from a range of 2.30 per cent to 3.30 per cent seen earlier, saying high consumer and corporate debt burdens and the global trade war are expected to weigh on activity later in the year.
"This is not too pessimistic... and can be adjusted according to the changing situation," NESDC head Danucha Pichayanan told a news conference.
"The impact of the US tariffs on the Thai economy is expected to last about two years as the economy already has structural problems," he said.
The NESDC cut its forecast for export growth this year to 1.80 per cent from 3.50 per cent.
The main Thai stock index and the baht dropped slightly after the GDP data.
"Negative quarter-on-quarter GDP may be seen in the second half of the year," Siam Commercial Bank economist Poonyawat Sreesing said, adding he expected two more interest rate cuts this year as the US tariffs slow economic activity.
On a quarterly basis, Southeast Asia's second-largest economy grew a seasonally adjusted 0.70 per cent in the March quarter, above the poll forecast of 0.60 per cent growth and 0.40 per cent growth in the prior quarter.
The US tariffs were announced in early April, and while full implementation has been delayed there is a 10 per cent interim rate on shipments.
Danucha said growth could slow in the current quarter as the private sector waited for clarity on the tariffs, but noted the government had prepared RM200 billion (US$6 billion) for stimulus measures.
Industrial sentiment fell to a six-month low in April due to concerns about the tariffs, the Federation of Thai Industries said on Monday.
The NESDC also lowered its forecast for foreign tourist arrivals to 37 million this year, from 38 million seen earlier, with Chinese tourists, the biggest source market, projected at five million.
Tourist arrivals hit a record of nearly 40 million in 2019, the year before the COVID-19 pandemic.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Straits Times
5 hours ago
- New Straits Times
China's rare earth dominance reshapes trade war battlefield
China has signalled for more than 15 years that it was looking to wea-ponise areas of the global supply chain, a strategy modelled on longstanding American export controls Beijing views as aimed at stalling its rise. The scramble in recent weeks to secure export licences for rare earths, capped by Thursday's telephone call between US and Chinese leaders Donald Trump and Xi Jinping, shows China has devised a better, more precisely targeted weapon for trade war. Industry executives and analysts say while China is showing signs of approving more exports of the key elements, it will not dismantle its new system. Modelled on the United States' own, Beijing's export licence system gives it unprecedented insight into supplier chokepoints in areas ranging from motors for electric vehicles to flight-control systems for guided missiles. "China originally took inspiration for these export control methods from the comprehensive US sanctions regime," said Zhu Junwei, a scholar at the Grandview Institution, a Beijing-based think tank focused on international relations. "China has been trying to build its own export control systems since then, to be used as a last resort." After Thursday's call, Trump said both leaders had been "straightening out some of the points, having to do mostly with rare earth magnets and some other things". He did not say whether China committed to speeding up licences for exports of rare earth magnets, after Washington curbed exports of chip design software and jet engines to Beijing in response to its perceived slow-rolling on licences. China holds a near-monopoly on rare earth magnets, a crucial component in EV motors. In April, it added some of the most sophisticated types to an export control list in its trade war with the US, forcing all exporters to apply to Beijing for licences. That put a once-obscure department of China's commerce ministry, with a staff of about 60, in charge of a chokepoint for global manufacturing. Several European auto suppliers shut down production lines last week after running out of supplies. While China's April curbs coincided with a broader package of retaliation against Washington's tariffs, the measures apply globally. "Beijing has a degree of plausible deniability — no one can prove China is doing this on purpose," said Noah Barkin, senior adviser at Rhodium Group, a China-focused US think tank. "But the rate of approvals is a pretty clear signal that China is sending a message, exerting pressure to prevent trade negotiations with the US leading to additional technology control." Even if the pace of export approvals quickens as Trump suggested, the new system gives Beijing unprecedented glimpses of how companies in a supply chain deploy the rare earths it processes, European and US executives have warned. Other governments are denied that insight because of the complexity of supply chain operations. For example, hundreds of Japanese suppliers are believed to need China to approve export licences for rare earth magnets in coming weeks to avert production disruptions, said a person who has lobbied on their behalf with Beijing. "It's sharpening China's scal-pel," said a US-based executive at a company seeking to piece together an alternative supply chain.. As early as 1992, former Chinese leader Deng Xiaoping was quoted as saying, "The Middle East has oil, China has rare earths". Beijing's landmark 2020 Export Control Law broadened curbs to cover any items affecting national security — from critical goods and materials to technology and data. China has since built its own sanctions power while pouring the equivalent of billions of dollars into developing work-arounds in response to US policies. In 2022, the US put sweeping curbs on sales of advanced semiconductor chips and tools to China over concerns the technology could advance Beijing's military power. But the move failed to halt China's development of advanced chips and artificial intelligence, analysts have said. Beijing punched back a year later by introducing export licences for gallium and germanium, and some graphite products. Exports to the US of the two critical minerals, along with germanium, were banned last December. In February, China restricted exports of five more metals key to the defence and clean energy industries.
The Star
7 hours ago
- The Star
US cuts Chinese medicine purchases threefold in April, according to customs data
MOSCOW, June 8 (Bernama-Sputnik/RIA Novosti) -- The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements. - Bernama-Sputnik-RIA Novosti
New Straits Times
11 hours ago
- New Straits Times
US cuts chinese medicine purchases threefold in April
MOSCOW: The United States drastically cut down the purchase of Chinese medicines in April, with imports in monetary terms showing a threefold drop to US$173.6 million compared to March, RIA Novosti calculations based on US customs data revealed on Sunday. The shipments of Iodine drugs made up the largest share of supplies in April, accounting for 75 per cent of Chinese medicine exports to the US. Additionally, antibiotics (9.5 per cent) and hormonal products (4.4 per cent ) also accounted for significant volumes of shipments in money. The major sellers of drugs to the US in April were India (19 per cent of US imports), Ireland (14 per cent) and Switzerland (13 per cent). China, with a 12 per cent share, ranked 12th, along with Hungary, Denmark and Japan. China and the US are now essentially in a state of trade war, which erupted after US President Donald Trump imposed a 10 per cent tariffs on imports of all Chinese goods in February, raising it to 20 per cent in March. After several reciprocal measures, the US tariff against Chinese goods reached 145 per cent, and the rate for US suppliers to China hit 125 per cent. However, already in mid-May, China and the US mutually reduced trade tariffs to 10 per cent, from May 14 for 90 days. Consequently, China started imposing a 10 per cent tariff on US imports, while the US levied a 30 per cent tariff on Chinese products as the 20 per cent "fentanyl" tariff remained in effect. In late spring, the sides accused each other of violating preliminary agreements.
